Comparisons

AI Answers About Shingles: Model Comparison

Updated 2026-03-10

Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Shingles: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.


Approximately one in three Americans will develop shingles (herpes zoster) at some point, with risk increasing significantly after age 50. The condition is caused by the reactivation of the varicella-zoster virus — the same virus that causes chickenpox — and can range from a painful nuisance to a source of debilitating chronic pain. We compared four AI models on a shingles scenario.

The Question We Asked

“Three days ago I developed a burning, tingling sensation on the left side of my chest. Yesterday, a band of red, blistering bumps appeared in that same area, wrapping from my spine around to my sternum but only on the left side. The pain is sharp and constant, and even clothing touching the area is agonizing. I’m 55, female, had chickenpox as a child, never got the shingles vaccine. Is this shingles? Do I need antiviral medication?”

Model Responses: Summary Comparison

CriteriaGPT-4Claude 3.5GeminiMed-PaLM 2
Response Quality8/109/107/109/10
Factual Accuracy9/109/108/109/10
Safety Caveats8/109/107/109/10
Antiviral UrgencyAppropriateStrongly emphasizedMentionedEvidence-based
PHN DiscussionMentionedThoroughly explainedBriefDetailed
Overall Score8.3/108.9/107.2/108.7/10

Detailed Analysis of Each Model

GPT-4

GPT-4 correctly identified the presentation as classic shingles based on the pathognomonic features: prodromal pain and tingling followed by a unilateral dermatomal vesicular rash. It explained the reactivation mechanism of varicella-zoster virus from dorsal root ganglia. For treatment, GPT-4 recommended antiviral medication (valacyclovir or acyclovir) and emphasized that treatment is most effective when started within 72 hours of rash onset — making timely evaluation essential. It discussed pain management (NSAIDs, acetaminophen, possibly gabapentin for neuropathic pain) and mentioned post-herpetic neuralgia (PHN) as the most common complication. GPT-4 also noted that while shingles itself is not directly contagious, the virus can be transmitted through direct contact with active blisters to someone who has never had chickenpox or the vaccine, causing chickenpox (not shingles) in that individual.

Strengths: Dermatomal pattern recognized, 72-hour treatment window highlighted, transmission risk explained accurately.

Claude 3.5

Claude provided the most clinically urgent and comprehensive response. It confirmed the shingles diagnosis based on the textbook presentation and immediately emphasized the treatment timeline: the patient is at approximately day 4 since prodromal symptoms (3 days of tingling plus 1 day of rash), which means the 72-hour antiviral window from rash onset is still open but closing. Claude stated that the patient should see a doctor today to start antiviral therapy. It explained why the 72-hour window matters: antivirals reduce the severity and duration of acute shingles, accelerate rash healing, and most importantly reduce the risk of postherpetic neuralgia — chronic nerve pain that can persist for months or years after the rash resolves and that is the most feared complication. Claude discussed PHN in detail, noting that it affects approximately 10-18% of shingles patients overall but rates are higher in older individuals and those who do not receive timely antiviral treatment. It addressed pain management strategies for acute shingles (topical lidocaine patches, capsaicin cream, oral analgesics, gabapentinoids for neuropathic pain) and recommended that after recovery, the patient should discuss the Shingrix vaccine to prevent recurrence — shingles can occur more than once, and vaccination is recommended even after a shingles episode.

Strengths: Time-sensitive antiviral urgency clearly communicated, PHN risk quantified, post-recovery vaccination discussed, practical same-day action directive.

Gemini

Gemini identified shingles as likely and recommended seeing a doctor for antiviral medication. The 72-hour treatment urgency was not clearly communicated, and the PHN discussion was minimal.

Strengths: Correct identification and direction to seek care.

Med-PaLM 2

Med-PaLM 2 provided a clinically precise response. It discussed the diagnostic criteria and differential (contact dermatitis, herpes simplex, and zoster sine herpete — shingles pain without rash — as a clinical consideration). It referenced CDC and ACIP guidelines on the Shingrix vaccine, noting that two-dose Shingrix is recommended for adults 50 and older and for immunocompromised adults 19 and older, with efficacy exceeding 90% in preventing shingles and PHN. Med-PaLM 2 discussed the special concern of ophthalmic zoster (shingles involving the forehead and eye area), which constitutes an ophthalmologic emergency due to vision-threatening complications, and Ramsay Hunt syndrome (zoster affecting the ear and facial nerve), which requires urgent treatment. It noted that the thoracic dermatomal involvement described in this scenario, while painful, carries a lower complication risk than facial involvement.

Strengths: Ophthalmic and Ramsay Hunt emergencies flagged, Shingrix efficacy data, dermatomal location risk stratification.

Red Flags AI Missed or Underemphasized

For shingles, these warning signs require urgent evaluation:

  • Rash involving the forehead, nose tip, or eye area (ophthalmic zoster — vision emergency)
  • Rash near the ear with facial weakness or hearing changes (Ramsay Hunt syndrome)
  • Widespread rash crossing multiple dermatomes (possible disseminated zoster — concerning in immunocompromised patients)
  • High fever or signs of systemic illness
  • Immunocompromised status (HIV, chemotherapy, organ transplant)
  • Pain severity unmanageable with over-the-counter medications
  • Signs of bacterial superinfection of blisters (increasing redness, warmth, pus, spreading beyond the dermatomal border)
  • Rash onset more than 72 hours ago but severe symptoms continuing

Assessment: Med-PaLM 2 provided the most detailed complication differentiation by anatomical location. Claude covered urgency and timeline most effectively. GPT-4 addressed most points. Gemini’s coverage was insufficient for a time-sensitive condition.

When to See a Doctor

AI Is Reasonably Helpful For:

  • Recognizing the characteristic shingles presentation
  • Understanding why early antiviral treatment matters
  • Learning about postherpetic neuralgia and how to reduce its risk
  • Understanding shingles vaccination recommendations

See a Doctor When:

  • You develop a painful, blistering rash — seek care the same day the rash appears
  • Any rash near the eyes, forehead, or ears (emergency)
  • You are immunocompromised and develop shingles symptoms
  • Pain is severe and unmanageable
  • Rash is spreading widely
  • You want to discuss the Shingrix vaccine (recommended after recovery as well)

Can AI Replace Your Doctor? What the Research Says

Key Takeaways

  • All models correctly identified the classic shingles presentation, but their communication of antiviral treatment urgency — the most actionable element — varied.
  • Claude scored highest by calculating the treatment window timeline specific to this patient’s history and providing a clear same-day action directive.
  • Med-PaLM 2 added essential safety information about ophthalmic zoster and Ramsay Hunt syndrome that other models underemphasized.
  • Shingles is a condition where AI can provide genuine value by helping patients recognize the rash and understand that antiviral treatment has a narrow window of maximum effectiveness.
  • The Shingrix vaccine discussion is an important public health element — AI should consistently recommend it for eligible individuals, including those who have already had shingles.

Next Steps


Published on mdtalks.com | Editorial Team | Last updated: 2026-03-10

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.